TERT genetic polymorphism rs2736100 is associated with an aggressive manifestation of papillary thyroid carcinoma
- PMID: 36704521
- PMCID: PMC9871626
- DOI: 10.3389/fsurg.2022.1019180
TERT genetic polymorphism rs2736100 is associated with an aggressive manifestation of papillary thyroid carcinoma
Abstract
Objectives: TERT rs2736100 genetic polymorphism is commonly found in human malignancies, indicating its key role in cancer cell transformation. The aim of this study is to investigate the effects of the functional TERT rs2736100 genetic polymorphism on the outcomes of papillary thyroid carcinoma (PTC) patients.
Materials and methods: We performed a retrospective study on the relationship between rs2736100 and clinicopathological outcomes of PTC in 500 patients (378 females and 122 males) aged 43.8 ± 11.4 years (range 15-74 years) with a median follow-up of 60 months (range, 1-455 months).
Results: TERT rs2736100 genetic polymorphism (TG/GG vs. TT) was significantly associated with several high-risk clinicopathological features such as tumor spread, extrathyroidal extension, central/lateral lymph node metastases, and Stage T III or IV disease. However, in Kaplan-Meier survival analyses, the rs2736100 mutation was unrelated to overall disease-free survival with a log-rank value of p > 0.05. In Cox-regression analyses, the overall survival rate of recurrence/neo-metastasis was related to a larger tumor size, younger age, and tumor spread but unrelated to the rs2736100 mutation.
Conclusions and significance: TERT rs2736100 genetic polymorphism mutation is more likely to manifest with aggressive clinicopathological characteristics but cannot worsen prognosis in PTC.
Keywords: TERT; manifestation; papillary thyroid carcinoma (PTC); polymorphism; rs2736100.
© 2023 Nie, Shang and Wang.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures

Similar articles
-
Association between hTERT Polymorphisms and Female Papillary Thyroid Carcinoma.Recent Pat Anticancer Drug Discov. 2019;14(3):268-279. doi: 10.2174/1574892814666190919145453. Recent Pat Anticancer Drug Discov. 2019. PMID: 31538903
-
[Clinicopathological features and molecular characteristics of tall cell and hobnail variants of papillary thyroid carcinoma].Zhonghua Bing Li Xue Za Zhi. 2021 Nov 8;50(11):1234-1239. doi: 10.3760/cma.j.cn112151-20210630-00473. Zhonghua Bing Li Xue Za Zhi. 2021. PMID: 34719160 Chinese.
-
Co-existence of BRAFV600E and TERT promoter mutations in papillary thyroid carcinoma is associated with tumor aggressiveness, but not with lymph node metastasis.Cancer Manag Res. 2018 May 3;10:1005-1013. doi: 10.2147/CMAR.S159583. eCollection 2018. Cancer Manag Res. 2018. PMID: 29760568 Free PMC article.
-
The TERT rs2736100 polymorphism and cancer risk: a meta-analysis based on 25 case-control studies.BMC Cancer. 2012 Jan 5;12:7. doi: 10.1186/1471-2407-12-7. BMC Cancer. 2012. PMID: 22221621 Free PMC article. Review.
-
Relationship between genetic alterations and clinicopathological characteristics of papillary thyroid carcinoma.Med Mol Morphol. 2019 Dec;52(4):181-186. doi: 10.1007/s00795-019-00217-6. Epub 2019 Feb 20. Med Mol Morphol. 2019. PMID: 30788603 Review.
Cited by
-
Telomere length and TERT polymorphisms as biomarkers in asbestos-related diseases.Radiol Oncol. 2024 Feb 21;58(1):87-98. doi: 10.2478/raon-2024-0009. eCollection 2024 Mar 1. Radiol Oncol. 2024. PMID: 38378028 Free PMC article.
-
A computational approach to assessing the prognostic implications of BRAF and RAS mutations in patients with papillary thyroid carcinoma.Endocrine. 2024 Nov;86(2):707-722. doi: 10.1007/s12020-024-03911-3. Epub 2024 Jun 17. Endocrine. 2024. PMID: 38886331
-
Telomeres and telomerase in mesothelioma: Pathophysiology, biomarkers and emerging therapeutic strategies (Review).Int J Oncol. 2025 Mar;66(3):23. doi: 10.3892/ijo.2025.5729. Epub 2025 Feb 21. Int J Oncol. 2025. PMID: 39981889 Free PMC article. Review.
References
LinkOut - more resources
Full Text Sources
Miscellaneous